Source:http://linkedlifedata.com/resource/pubmed/id/10376773
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1999-7-16
|
pubmed:abstractText |
The thiopurine methyltransferase (TPMT) genetic polymorphism has been shown to have a highly significant clinical impact, namely in the therapeutic efficiency of thiopurine drugs used in the treatment of a wide range of diseases. Available diagnostic methods, although reproducible and sensitive, are relatively laborious. Thus population studies are still very scarce. In this work we describe a new polymerase chain reaction-single strand confirmational analysis based protocol for TPMT specific detection which introduces a substantial technical simplification avoiding the use of restriction enzyme treatment after polymerase chain reaction amplification. Additionally, the use of this protocol allows the simultaneous detection of a T474 to C substitution, a frequent silent mutation in the North Portuguese population (TPMT*1S = 0.215). In a sample of 310 unrelated Northern Portuguese individuals, 15 were found to be heterozygous for the TPMT*3A allele (defined by the presence of two transitions, G460 to A and A719 to G) which is associated with TPMT enzymatic deficiency; the corresponding gene frequency estimate was 0.024. We also attempted to evaluate the relationship between the molecular TPMT genotype and the reaction to treatments involving thiopurine drugs by analysing a sample of 24 children submitted to curative therapy of acute lymphoblastic leukaemia. Four of them were shown to be heterozygous for the TPMT*3A allele. An examination of their clinical histories showed that all four patients exhibited signs of severe hepatic toxicity during treatment.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/DNA Primers,
http://linkedlifedata.com/resource/pubmed/chemical/Methyltransferases,
http://linkedlifedata.com/resource/pubmed/chemical/Purines,
http://linkedlifedata.com/resource/pubmed/chemical/thiopurine methyltransferase
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0960-314X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
9
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
257-61
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10376773-Antineoplastic Agents,
pubmed-meshheading:10376773-Base Sequence,
pubmed-meshheading:10376773-Child,
pubmed-meshheading:10376773-DNA Primers,
pubmed-meshheading:10376773-Heterozygote,
pubmed-meshheading:10376773-Humans,
pubmed-meshheading:10376773-Methyltransferases,
pubmed-meshheading:10376773-Pharmacogenetics,
pubmed-meshheading:10376773-Polymorphism, Restriction Fragment Length,
pubmed-meshheading:10376773-Portugal,
pubmed-meshheading:10376773-Precursor Cell Lymphoblastic Leukemia-Lymphoma,
pubmed-meshheading:10376773-Purines
|
pubmed:year |
1999
|
pubmed:articleTitle |
Thiopurine methyltransferase pharmacogenetics: alternative molecular diagnosis and preliminary data from Northern Portugal.
|
pubmed:affiliation |
IPATIMUP, Faculdade de Ciências da Universidade do Porto, Portugal.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|